ArticleJournal of clinical medicine2026

Is Neoadjuvant Chemoimmunotherapy Safe in Surgically High-Risk Lung Cancer Patients? A Single-Centre IPTW Analysis.

Fathima Shafra Mubarak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.